512 related articles for article (PubMed ID: 35751653)
21. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
Norooznezhad AH; Mansouri K
Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
[TBL] [Abstract][Full Text] [Related]
22. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
Quirch M; Lee J; Rehman S
J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
[TBL] [Abstract][Full Text] [Related]
23. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After Recovery.
Kumar NP; Venkataraman A; Nancy A; Moideen K; Varadarjan P; Selladurai E; Sangaralingam T; Selvam R; Thimmaiah A; Natarajan S; Ramasamy G; Hissar S; Radayam Ranganathan U; Babu S
J Infect Dis; 2022 Sep; 226(7):1215-1223. PubMed ID: 35932220
[TBL] [Abstract][Full Text] [Related]
25. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
[TBL] [Abstract][Full Text] [Related]
26. Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
Borgia F; Li Pomi F; Alessandrello C; Vaccaro M; Pioggia G; Gangemi S
J Dermatol; 2022 Oct; 49(10):948-956. PubMed ID: 35675487
[TBL] [Abstract][Full Text] [Related]
27. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Hsu RJ; Yu WC; Peng GR; Ye CH; Hu S; Chong PCT; Yap KY; Lee JYC; Lin WC; Yu SH
Front Immunol; 2022; 13():832394. PubMed ID: 35464491
[TBL] [Abstract][Full Text] [Related]
28. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm.
Rabaan AA; Al-Ahmed SH; Muhammad J; Khan A; Sule AA; Tirupathi R; Mutair AA; Alhumaid S; Al-Omari A; Dhawan M; Tiwari R; Sharun K; Mohapatra RK; Mitra S; Bilal M; Alyami SA; Emran TB; Moni MA; Dhama K
Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946736
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
[TBL] [Abstract][Full Text] [Related]
30. The Relation of the Viral Structure of SARS-CoV-2, High-Risk Condition, and Plasma Levels of IL-4, IL-10, and IL-15 in COVID-19 Patients Compared to SARS and MERS Infections.
Mousavizadeh L; Soltani R; Abedini K; Ghasemi S
Curr Mol Med; 2022; 22(7):584-593. PubMed ID: 34607539
[TBL] [Abstract][Full Text] [Related]
31. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
[TBL] [Abstract][Full Text] [Related]
32. Cytokine storm induced by SARS-CoV-2.
Song P; Li W; Xie J; Hou Y; You C
Clin Chim Acta; 2020 Oct; 509():280-287. PubMed ID: 32531256
[TBL] [Abstract][Full Text] [Related]
33. COVID-19 and lung cancer: risks, mechanisms and treatment interactions.
Addeo A; Obeid M; Friedlaender A
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32434788
[TBL] [Abstract][Full Text] [Related]
34. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
35. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
[TBL] [Abstract][Full Text] [Related]
36. Fatal outcome of severe fever with thrombocytopenia syndrome (SFTS) and severe and critical COVID-19 is associated with the hyperproduction of IL-10 and IL-6 and the low production of TGF-β.
Kang SY; Yoo JR; Park Y; Kim SH; Heo ST; Park SH; Kim M; Kim TJ; Oh S; Lee MS; Kim JM; Cho NH; Lee KM; Lee KH
J Med Virol; 2023 Jul; 95(7):e28894. PubMed ID: 37386895
[TBL] [Abstract][Full Text] [Related]
37. COVID-19: Inflammatory Profile.
Wang Y; Perlman S
Annu Rev Med; 2022 Jan; 73():65-80. PubMed ID: 34437814
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
39. Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent.
Declercq J; De Leeuw E; Lambrecht BN
Cytokine; 2022 Sep; 157():155934. PubMed ID: 35709568
[TBL] [Abstract][Full Text] [Related]
40. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
Torabi-Rahvar M; Rezaei N
Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
